Advanced searches left 3/3

Cushing's Syndrome - Europe PMC

Summarized by Plex Scholar
Last Updated: 16 January 2022

* If you want to update the article please login/register

Cushing's syndrome due to ectopic adrenocorticotropin secretion by a parotid carcinoma.

paraphrased gland, locally acinic cell carcinoma of the parotid gland, in a 37-year-old female who onset Cushing's syndrome in a 37-year-old female who first developed with localized Cushing's syndrome. The patient was scheduled for recovery after facial nerve destruction with facial nerve sacrifice, but there were no signs of disease. On the face and upper trunk, the patient recovered respiratory infection and gained weight, but the patient's facial plethora and acne persists. Acth in the lung biopsy revealed good positive staining for ACTH, confirming a diagnosis of ectopic ACTH secretion by a metastatic parotid cell carcinoma. After the fifth cycle of chemotherapy, ketoconazole was stopped and the patient was in remission of CS for four months, when CS recurred. Patients with high-grade salivary gland carcinomas may have CS features, but patients with high-grade salivary gland carcinomas should be concerned with potential CS issues, since the diagnosis of ectopic carcinoma of ACTH can have a major effect on their treatment and outcomes.

Source link: https://europepmc.org/article/MED/35029850


Frequency and risk factors for naturally occurring Cushing's syndrome in dogs attending UK primary-care practices.

Objects: To determine the incidence and risk factors for Cushing's syndrome in dogs under UK primary veterinary care, it's best to determine the incidence and risk factors for Cushing's syndrome. Methods and methods Dogs with Cushing's syndrome were identified by searching electronic patient records of primary-care veterinary services. To estimate the 1-year period prevalence, the 1-year period prevalence was based on pre-existing and incident cases of Cushing's syndrome during 2016. Through multivariable logistic regression, multiple independent logistic regression methods were used to determine the annual prevalence and disease risk factors for the diagnosis of Cushing's syndrome in dogs. Results An analysis of 970 pre-existing and 557 incident cases of Cushing's syndrome from a population of 905,544 dogs was included in the study. According to the estimated 1-year prevalence of Cushing's syndrome in dogs under veterinary care, it was 0. 17 percent and incidence was 0. 06%. The Bichon frise, Border terrier, and Miniature schnauzer had the highest chances of Cushing's syndrome in multivariable logistic regression simulations. The Golden retriever and Labrador retriever were the most covered breeds.

Source link: https://europepmc.org/article/MED/34881823


Cushing's syndrome caused by intra-adrenocortical adrenocorticotropic hormone in a dog.

An adrenocortic hormone expression in a 13-year-old Labrador retriever was diagnosed with Cushing' syndrome, a primary bilateral nodular hyperplasia with primary bilateral nodular hyperplasia with adrenocortical hyperplasia with primary bilateral nodular hyperplasia with adrenocortical hyperplasia with primary bilateral nodular hyperplasia with adrenocortical hyperplasia Multiple cell clusters distributed in both adrenal glands, at the junction of the fascicular and glomerular zones, expressed ACTH, whereas the pheochromocytoma cells did not. Therefore, the term ACTH-independence may be misleading in certain cases of bilateral adrenocortical hyperplasia and reduced plasma ACTH levels in dogs.

Source link: https://europepmc.org/article/MED/34859494


Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review.

Patients with CS complicated by cardiomyopathies were diagnosed with cardiomyopathies, and method: The clinical records of patients with CS complicated with cardiomyopathies were obtained from discharge sheets from Peking Union Medical College Hospital from January 1986 to August 2021. Results: A total of 19 cases of CS complicated by cardiomyopathies and cases of CD without cardiomyopathies were collected. In the serum cortisol concentration and 24-h urine free cortisol levels, there were no significant differences between the CS complicated with cardiomyopathies group and the CD patients without cardiomyopathy in the serum cortisol concentration and 24-h urine free cortisol, but there was no significant difference in the adotropic hormone level [109. 00 pg/ml]. After remission of hypercortisolemia following CS therapy, 12/16 patients showed dramatic improvement or even complete restoration of the heart structure and function.

Source link: https://europepmc.org/article/MED/34926625


Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing's Syndrome Patients: A Cross-Sectional Study.

BACKGROUND Glucose metabolism in patients with Cushing's syndrome is often impaired by chronic exposure to elevated glucocorticoids. Inflammation plays a vital role in diabetes mellitus' pathophysiology. The present research was designed to investigate the potential relationships of inflammatory blood cell counts, neutrophil count, neutrophil number, lymphocyte count, and lymphocyte proportion in Cushing's syndrome patients with diabetes mellitus. Patients with Cushing's syndrome were retrospectively tested from 2017 to 2019. Results of this study The prevalence of diabetes mellitus in patients with Cushing's syndrome was 38. 7% in patients with Cushing's syndrome. Patients with DM had elevated WBC, neutrophil, and NEUT% values than those without DM. Conclusions In conclusion, raised NEUT% level in patients with Cushing's syndrome was related to diabetes. The neutrophilic granulocyte percentage may be used as a new predictor of diabetes in Cushing's syndrome patients.

Source link: https://europepmc.org/article/MED/34880914


Molecular derangements and the diagnosis of ACTH-Dependent Cushing's syndrome.

It discusses current research of the control of ACTH synthes and secrecy by normal corticotropes, as well as the ways by which dysregulation occurs in corticotrope and non-corticotrope ACTH-producing tumors. ACTH leads to adrenal gland production and pulsatile release of cortisol in these CS forms; excessive ACTH in these CS contributes to endogenous CS hypercortisolism. The difference between healthy people and those with CS is also shown by the differences between healthy people and those with CS. The clinical findings and their use in the interpretation of CS screening results are described.

Source link: https://europepmc.org/article/MED/34849663


Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome.

The definitive analysis used 40 miRNAs from blood samples of healthy dogs, dogs with PDH, and dogs with a csACT. The expression levels in healthy dogs and dogs with PDH were not similar between healthy dogs and dogs with PDH, significantly reduced after hypophysectomy, and dogs with recurrence were much higher in dogs with recurrence than in dogs without recurrence for at least one year after hypophysectomy. Two miRNAs were significantly expressed in dogs with csACTs and in healthy dogs relative to healthy dogs. In addition, miR-141-3p was significantly lower in dogs with csACTs with a histopathological Utrecht score of 11 compared to those with a score of 11. These findings indicate that circulating miRNAs in dogs with Cushing's syndrome may be non-invasive biomarkers that may be useful in clinical decision making.

Source link: https://europepmc.org/article/MED/34869733


Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.

Patients Eleven patients with MTC and incidence of ECS, as well as 22 matched MTC patients without ECS were included in the study. Measurements The main endpoint of this review was the overall survival in MTC patients with ECS compared to 1:1 matched MTC patients without ECS. Results The median age at diagnosis of ECS was 59 years, while the median time between MTC diagnosis and diagnosis of ECS was 29 months. ECS treatment included bilateral adrenalectomy in four patients and adrenostatic therapy in eight patients. Patients with ECS had a shorter median OS of 87 months than matched controls, with a shorter median OS of 87 months than matched controls. Adrenostatic therapy and BADX were both effective systemic therapy options in patients with MTC and ECS with hypercortisolism. In one treated case, MKI therapy resulted in complete remission of hypercortisolism and stable tumor control.

Source link: https://europepmc.org/article/MED/34743368

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions